CY2019004I2
(en )
2019-11-27
MODIFIED ANTI-IL-23P19 ANTIBODIES
LTPA2020523I1
(en )
2020-08-10
Anti-CD79b antibodies and immunoconjugates and their uses
SMT201700083B
(en )
2017-03-08
MONOCLONAL ANTIBODIES
BRPI0822447A2
(en )
2015-06-16
Monoclonal antibody and method thereof
SMT201400184B
(en )
2015-01-15
Monoclonal antibodies that b7h6 bind and their uses
BRPI0907237A2
(en )
2015-07-14
Anti-cldn6 antibody
BRPI0906478A2
(en )
2015-11-24
anti-nr10 antibody and its use
DK3091034T3
(en )
2020-06-15
Anti-CD40 antibodies and uses thereof
DK2118140T3
(en )
2013-07-01
HUMANCY SYTOMEGALOVIRUS-NEUTRALIZING ANTIBODIES AND USE THEREOF
BRPI0914943A2
(en )
2013-09-17
il-6 antibodies and their use
BRPI1012676A2
(en )
2016-04-05
anti-fcrh5 and immunoconjugate antibodies and methods of use
BRPI1012560A2
(en )
2016-07-26
anti-fcrh5 and immunoconjugate antibodies and methods of use
FI20075278A0
(en )
2007-04-20
Novel completely human anti-VAP-1 monoclonal antibodies
BRPI0817273A2
(en )
2015-06-16
Modified antibody constant region
EP2236604A4
(en )
2012-08-01
Anti-nr10 antibody and use thereof
DK2234600T3
(en )
2014-09-08
ANTIBODY FORMULATION
BRPI0820298A8
(en )
2018-05-08
anti-vegf antibody compositions and methods
NO344963B1
(en )
2020-08-03
Humanized antibody
BRPI0809677A2
(en )
2014-10-07
Anti-GSE Antibodies
BRPI0907532A2
(en )
2015-07-28
Humanized anti-c5ar antibodies
EP2411050A4
(en )
2013-07-17
Antibody constant domain regions and uses thereof
BRPI0814111A2
(en )
2015-02-03
CYTOTOXIC MONOCLONAL ANTIBODY
BRPI0817427A2
(en )
2015-06-16
Anti-bst2 antibody
EP2593475A4
(en )
2014-03-05
Anti-addl monoclonal antibody and uses thereof
HK1203206A1
(en )
2015-10-23
Antibody and use thereof